Log in to search using one of your social media accounts:

 

Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure
Whole pelvic radiation therapy (WPRT) and androgen deprivation therapy (ADT) reduce the risk of biochemical failure in men who receive post-prostatectomy salvage radiotherapy for prostate cancer, according to a database study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 22, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Children undergoing radiation for cancer may have alternative to sedation
(University of North Texas) Radiation therapy for children with cancer is painless, but preparation for it may cause great stress for a child and his or her family because the child is routinely sedated before each treatment, to stay motionless. Manish Vaidya at the University of North Texas is using a computer program to train young patients to stay motionless so sedation won't be necessary. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Jax company starts trial on cancer-fighting therapy
Jacksonville-based TapImmune Inc. (Nasdaq: TPIV) has enrolled its final patient in a randomized, Phase 2 clinical study of an immunotherapy that targets breast cancer. TapImmune's therapies help the body's immune system find and fight cancer, which has evolved to hide from and suppress it, CEO Peter Hoang previously told the Business Journal. This approach is outside of the box of traditional treatment methods like surgery, chemotherapy and radiation therapy tha t shut-down pathways for cancer to… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Will Robinson Source Type: news

ViewRay's net loss narrows in Q3
Image-guided radiation therapy developer ViewRay's net loss narrowed in its...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay raises $50M in stock sale ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 13, 2017 Category: Radiology Source Type: news

Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival
Survival after radical prostatectomy for prostate cancer is better among men who undergo androgen deprivation therapy (ADT) and external beam radiation therapy (EBRT), according to a retrospective analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 9, 2017 Category: Surgery Tags: Urology News Source Type: news

Augmenix touts AMA code, CMS reimbursement for SpaceOar
Augmenix said today that the American Medical Association established a Current Procedural Terminology code for its SpaceOar hydrogel and similar devices, with the Centers for Medicare and Medicaid Services setting a payment rate for procedures with the injectable. The Bedford, Mass.-based company said that the AMA established CPT code 55874 for the periprostatic implantation of biodegradable materials, which SpaceOar will be billed under. The code is set to go into effect January 1, 2018. Augmenix also noted that CMS promulgated their 2018 Medicare Hospital Outpatient Prospective Payment System rule to provide an ave...
Source: Mass Device - November 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Augmenix Inc. Source Type: news

IMV: Imaging sites happiest with mammo systems
Medical imaging facilities are most satisfied with the performance of their...Read more on AuntMinnie.comRelated Reading: IMV: Technology drives radiation therapy market IMV: Hospital cardiology moving beyond CPACS, CVIS Report: MRI scanner installed base is long in the tooth Report: CT procedure volume drops 11% over past 2 years IMV: Cath lab market to grow over next 3 years (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 7, 2017 Category: Radiology Source Type: news

Report: Doctor self-diagnoses cancer while testing Butterfly iQ ultrasound
A vascular surgeon was able to diagnose his own cancer while testing the Butterfly Network’s Butterfly iQ ultrasound-on-a-chip device, according to a report from USA Today. After experiencing some throat discomfort Dr. John Martin self-tested the device, designed to send images to and operate in conjunction with Apple (NSDQ:AAPL) iPhones, and found a mass that he thought looked cancerous, according to the report. The mass turned out to be squamous cell cancer which Martin has since received treatment for, including surgery and radiation therapy. “I felt something funny in my neck, connected the probe to my...
Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Imaging Oncology Apple butterflynetwork Source Type: news

More early stage lung cancer patients survive the disease
(Elsevier) With the advancement of surgical and radiation therapy strategies for stage 1 non-small-cell lung cancer (NSCLC), more patients are being treated, resulting in higher survival rates, according to a study published online today in The Annals of Thoracic Surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2017 Category: Cancer & Oncology Source Type: news

ViewRay raises $50M in stock sale
Image-guided radiation therapy developer ViewRay has raised approximately $50...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2017 Category: Radiology Source Type: news

ViewRay touts pancreatic cancer study results
Image-guided radiation therapy developer ViewRay is touting study results showing...Read more on AuntMinnie.comRelated Reading: ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system ViewRay sees drop in Q1 revenue (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2017 Category: Radiology Source Type: news

Proton therapy for prostate cancer is advantageous to imrt according to new study
(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2017 Category: International Medicine & Public Health Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news

2 Things that Go Together: Yoga and Advanced Lung Cancer 2 Things that Go Together: Yoga and Advanced Lung Cancer
Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Two Things That Go Together: Yoga and Advanced Lung Cancer Two Things That Go Together: Yoga and Advanced Lung Cancer
Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Yoga can be an effective supportive therapy for people with lung cancer and their caregivers
(American Society of Clinical Oncology) In a feasibility trial of people with advanced lung cancer receiving radiation therapy, and their caregivers, yoga was beneficial to both parties. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news

Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer
(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2017 Category: Cancer & Oncology Source Type: news

Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

Xstrahl lands FDA nod for superficial x-ray therapy
X-ray and radiation therapy technology developer Xstrahl has received U.S....Read more on AuntMinnie.comRelated Reading: Xstrahl sells 20th small-animal system Elekta adds Xstrahl interface Gulmay Medical becomes Xstrahl (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 17, 2017 Category: Radiology Source Type: news

CARTI Docs Again Get Highest Nonprofit Salaries
Oncologists from Central Arkansas Radiation Therapy Institute again dominate the list of the state’s highest-paid nonprofit employees, occupying four of the top five positions with total compensation of $1.57 million to $2.3 million in the fiscal year that ended June 30, 2016. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 16, 2017 Category: American Health Source Type: news

In High-Risk Endometrial Cancer, Adding Chemo No Help, but … In High-Risk Endometrial Cancer, Adding Chemo No Help, but …
Vaginal cuff brachytherapy plus chemotherapy was compared to standard radiation therapy alone. The results disappointed, but there is a caveat.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Elekta and The Alliance for Cancer Care Partner to Bring Leading-edge Radiation Therapy and Radiosurgery Solutions to Patients
The Alliance for Cancer Care converts all oncology treatment devices and software to Elekta products, improving and standardizing care across its multiple sites STOCKHOLM, Oct. 2, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) tod... Elekta, radiation therapy, radiation oncology, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 2, 2017 Category: Pharmaceuticals Source Type: news

Radiation Therapy for Cancer: Feared, Misunderstood Radiation Therapy for Cancer: Feared, Misunderstood
The word'radiation'triggers scary associations. But a study of breast cancer patients'attitudes about radiation therapy revealed that experience trumps fears. Still, the specialty has a lot of work to do.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 29, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Radiation and Chemotherapy Together Boost Lung Cancer Survival
About one-third of stage 3 patients alive after 5 years, a development called promising by oncologists Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Lung Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 27, 2017 Category: Consumer Health News Source Type: news

Hypofractionated RT: Safe and Effective After Mastectomy Hypofractionated RT: Safe and Effective After Mastectomy
Hypofractionated radiation therapy was not inferior to conventional fractionated radiation therapy in the postmastectomy setting, but questions remain.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC
Mature 5-year follow-up data from the RTOG 0617 trial confirm that a dose of 60 Gy is superior to 74 Gy in advanced inoperable non-small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Treatment That's Easy to Swallow in HPV+ Throat Cancer Treatment That's Easy to Swallow in HPV+ Throat Cancer
The radiation therapy dose for throat cancer was cut 50%, but the 2-year outcomes are still excellent, including no injury to patient swallowing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Radiation and Chemotherapy Together Boost Lung Cancer Survival
TUESDAY, Sept. 26, 2017 -- Combining radiation therapy with chemotherapy has substantially extended survival for many people with lung cancer, two new studies report. About 32 percent of non-small cell lung cancer patients who received... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 26, 2017 Category: General Medicine Source Type: news

ASTRO: Breast radiation 'less scary' than expected
Breast cancer patients find the experience of radiation therapy to be less...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer ASTRO awards $275K to researchers ASTRO honors 43 researchers at annual meeting ACR, ASTRO, AAPM provide guidance updates ASTRO updates insurance coverage policies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2017 Category: Radiology Source Type: news

High-precision radiotherapy for prostate cancer 'shows promise'
Conclusion This study shows some promising results for targeted pelvic lymph node radiotherapy for men with advanced localised prostate cancer. However, these results can only be treated as preliminary findings for now. This was an early-stage trial that aimed to investigate whether the treatment approach is safe and to get an idea of what doses may be suitable for assessment in further trials. Although it can give an indication of effectiveness, this was not the main aim of the study. Men were not randomised to a treatment group, which means there may have been some differences in the cancers or patient characteristics of...
Source: NHS News Feed - September 26, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

ASTRO: Short radiation course safe for breast cancer
A shorter-course, higher-dose protocol for breast cancer radiation therapy...Read more on AuntMinnie.comRelated Reading: LED device could predict skin damage from breast RT Breast cancer radiation boosts heart disease risk NEJM: RT boosts heart disease risk in breast cancer patients Robotic IMRT-APBI works well for breast cancer patients ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2017 Category: Radiology Source Type: news

Uninsured cancer patients saw increased coverage for care following Medicaid expansion
(American Society for Radiation Oncology) A new study finds that Medicaid expansion enacted as part of the Patient Protection and Affordable Care Act improved coverage for care for cancer patients receiving radiation therapy and potentially decreased health care disparities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 26, 2017 Category: Cancer & Oncology Source Type: news

Immunotherapy Plus RT for Metastatic Cancer:'Step Forward'Immunotherapy Plus RT for Metastatic Cancer:'Step Forward '
Cancer treatment with radiation therapy typically attempts to achieve local control of tumors with direct hits of radiation therapy. Not this trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ViewRay launches multicenter trial for pancreatic cancer
Image-guided radiation therapy developer ViewRay launched a multicenter prospective...Read more on AuntMinnie.comRelated Reading: ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system ViewRay sees drop in Q1 revenue ViewRay boosts borrowing capacity (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news

Breast Cancer Radiation'Less Scary' Than Thought
Majority of patients report more tolerable experience than they expected Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 25, 2017 Category: Consumer Health News Source Type: news

Breast Cancer Radiation'Less Scary' Than Thought
MONDAY, Sept. 25, 2017 -- Radiation therapy for breast cancer is actually " less scary " than anticipated, nine out of 10 patients say after treatment. A survey of 300-plus breast cancer patients also found that more than 80 percent said the side... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 25, 2017 Category: General Medicine Source Type: news

Elekta inks stereotactic development, software, co-marketing deals
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer. Specifically, the companies plan to foc...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Alex Beall Tags: Business/Financial News Wall Street Beat Elekta Source Type: news

International trial confirms safety, effectiveness of HDR brachytherapy for cervical cancer
(American Society for Radiation Oncology) Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2017 Category: International Medicine & Public Health Source Type: news

Breast cancer patients largely find radiation therapy experience better than expected
(American Society for Radiation Oncology) A new survey finds breast cancer patients' actual radiation therapy experiences largely exceeded their expectations. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 25, 2017 Category: International Medicine & Public Health Source Type: news

Trial confirms pelvic radiation as standard of care for high-risk endometrial cancer
(American Society for Radiation Oncology) In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 25, 2017 Category: Cancer & Oncology Source Type: news

Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes
(Mayo Clinic) Mayo Clinic researchers have found that a 50 percent reduction in the intensity and dose of radiation therapy for patients with HPV-related throat cancer reduced side effects with no loss in survival and no decrease in cure rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 25, 2017 Category: Cancer & Oncology Source Type: news

Halving radiation therapy for HPV-related throat cancer offers fewer side effects and similar outcomes, Mayo study finds
SAN DIEGO ? Mayo Clinic researchers have found that a 50 percent reduction in the intensity and dose of radiation therapy for patients with HPV-related throat cancer reduced side effects with no loss in survival and no decrease in cure rates. Results of a phase II study were presented today at the 59th Annual Meeting [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - September 25, 2017 Category: Research Source Type: news

Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC
(American Society for Radiation Oncology) A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body's immune system to attack the cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 24, 2017 Category: Cancer & Oncology Source Type: news

Adding radiation to chemotherapy may dramatically improve survival for advanced NSCLC
(American Society for Radiation Oncology) Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 24, 2017 Category: Cancer & Oncology Source Type: news

Post-mastectomy Radiotherapy Affects Outcomes of Breast Reconstruction Post-mastectomy Radiotherapy Affects Outcomes of Breast Reconstruction
For women who have radiation therapy after mastectomy, autologous reconstruction is associated with a lower risk of complications and better satisfaction with outcome, compared with implant-based breast reconstruction.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain SAN DIEGO, September 22, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) and Brainlab have recon... Devices, Oncology, Neurosurgery Elekta, Brainlab, Versa HD, ExacTrac, stereotactic, radiosurgery, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

New payment models for radiation therapy should consider impact of behavioral health costs Mayo researchers say
SAN DIEGO ? Efforts to develop new payment models in radiation oncology also should consider measures to address behavioral health to reduce the total cost of care during and after radiotherapy, according to the results of study performed by researchers at Mayo Clinic and presented today at the 59th Annual Meeting of the American Society [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - September 22, 2017 Category: Research Source Type: news

Varian announces 1st patient treated with Halcyon
Radiation therapy firm Varian Medical Systems announced that a patient with...Read more on AuntMinnie.comRelated Reading: Varian updates treatment planning system Varian holds clinical workshop at Algerian facility Varian appoints new VP Varian inks deal with Bionix Varian treats 1st patient with HyperArc (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 21, 2017 Category: Radiology Source Type: news

New clinical trial explores combining immunotherapy and radiation for sarcoma patients
(University of Maryland Medical Center) University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to destroy the main tumor as well as leftover microscopic cancer cells that may seed other tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2017 Category: Cancer & Oncology Source Type: news